NCT06390826 2026-03-17Testing Sunitinib as Potentially Targeted Treatment in Cancers With cKIT Genetic Changes (MATCH - Subprotocol V)National Cancer Institute (NCI)Phase 2 Active not recruiting10 enrolled 10 charts